Press "Enter" to skip to content

Lupin contributes Rs 21 crores for COVID-19 Relief efforts

Pharma major Lupin today announced that it has contributed Rs. 21 crore towards Covid-19 relief efforts. In a press statement, the pharma company said, Lupin’s Global Giving Program comprises three separate contributions – from employees, company and the promoter family.

Lupin’s employees have contributed generously by giving two days of their individual salaries, together contributing a sum of Rs 5.5 crore to the Prime Minister’s Citizen Assistance and Relief in Emergency Situations Fund (PM CARES Fund),” the statement said. 

The company also added that Lupin has matched an equal sum (Rs. 5.5 crore) for direct initiatives that the company will implement to support overburdened national and state healthcare systems through donation of personal protective equipment, medicines and providing meals for front-line workers and the needy.

In addition, the promoter Desh Bandhu Gupta family has committed a sum of Rs. 10 crore for other direct impact initiatives in India and elsewhere in the world to supplement Lupin’s relief efforts to tackle the COVID-19 crisis.

“As one of the leading pharmaceutical companies globally, Lupin remains committed to ensure uninterrupted supply of medicines across India and global markets while ensuring safety of our personnel involved. We are grateful for this opportunity to support those who are at the front-line of this battle against COVID-19,” Nilesh Gupta, Managing Director, Lupin was quoted in the statement. 

Lupin, a leader in cardiovascular, anti-diabetic, and respiratory segments, has 15 manufacturing sites, 7 research centers with more than 20,000 professionals working across the globe. 

The company develops and commercializes a wide range of branded and generic formulations, biotechnology products and APIs in over 100 markets in the U.S., India, South Africa and across Asia Pacific (APAC), Latin America (LATAM), Europe and Middle-East regions.

Be First to Comment

Leave a Reply

Your email address will not be published.